Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Acute Myeloid Leukemia(AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00070551
What this trial is testing

GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+3 more
National Cancer Institute (NCI) 51
Large-scale testing (Phase 3)Study completedNCT00002945
What this trial is testing

High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute 61
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Study completedNCT00360672
What this trial is testing

Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Ended earlyNCT00119366
What this trial is testing

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+14 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Looking for participantsNCT06594445
What this trial is testing

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

Who this might be right for
Myeloid MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 45
Testing effectiveness (Phase 2)Study completedNCT00088218
What this trial is testing

Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 95
Testing effectiveness (Phase 2)Study completedNCT01541280
What this trial is testing

VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Nantes University Hospital 30
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03280030
What this trial is testing

Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 67
Testing effectiveness (Phase 2)Ended earlyNCT00818961
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Northside Hospital, Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT00066417
What this trial is testing

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
National Heart, Lung, and Blood Institute (NHLBI) 51
Early research (Phase 1)Ended earlyNCT05424380
What this trial is testing

A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS

Who this might be right for
Leukemia, Myeloid, Acute
GlaxoSmithKline 18
Not applicableLooking for participantsNCT07205523
What this trial is testing

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)Acute Myeloid Leukemia (AML)Leukemias, Acute Myeloid+12 more
Yigeng Cao,MD,PhD 1,000
Testing effectiveness (Phase 2)UnknownNCT00885508
What this trial is testing

The Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 85
Early research (Phase 1)Looking for participantsNCT07044544
What this trial is testing

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

Who this might be right for
Myeloid MalignancyHematologic MalignancyAcute Myeloid Leukemia+1 more
University of Alabama at Birmingham 20
Early research (Phase 1)Study completedNCT00986804
What this trial is testing

Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Washington University School of Medicine 24
Post-approval studies (Phase 4)UnknownNCT01806116
What this trial is testing

Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Higher-risk Myelodysplastic SyndromeRelapsed /Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 30
Early research (Phase 1)Study completedNCT04241549
What this trial is testing

Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment

Who this might be right for
Leukemia, Myeloid, Acute
OncoVerity, Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT06158828
What this trial is testing

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Who this might be right for
AML, ChildhoodAmlAcute Myeloid Leukemia, Pediatric+1 more
Washington University School of Medicine 68
Next Page
18